Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ONCOSEC MEDICAL Inc | VP, Finance | Common Stock | 1.01K | $1.38K | $1.37 | Feb 9, 2023 | Direct |
Acasti Pharma Inc. | Principal Financial Officer | Stock Options (Right to Buy) | 4.5K | May 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACST | Acasti Pharma Inc. | May 6, 2024 | 1 | $0 | 4 | May 8, 2024 | Principal Financial Officer |
ACST | Acasti Pharma Inc. | Jan 5, 2024 | 0 | $0 | 3 | Jan 8, 2024 | Vice President, Finance |
ONCS | ONCOSEC MEDICAL Inc | Feb 9, 2023 | 1 | -$55 | 4 | Feb 9, 2023 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Nov 4, 2022 | 1 | -$105 | 4 | Nov 4, 2022 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Aug 5, 2022 | 1 | -$202 | 4 | Aug 5, 2022 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | May 6, 2022 | 1 | -$227 | 4 | May 6, 2022 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Feb 9, 2022 | 1 | -$360 | 4 | Feb 11, 2022 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Nov 1, 2021 | 1 | -$600 | 4 | Nov 3, 2021 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Aug 1, 2021 | 1 | -$898 | 4 | Aug 3, 2021 | VP, Finance |
ONCS | ONCOSEC MEDICAL Inc | Jun 28, 2021 | 1 | $0 | 4 | Jun 29, 2021 | Vice President, Finance |